Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Department of Surgery, Union Hospital, Huazhong University of Science and Technology, Wuhan, P.R. China.
Hepatology. 2018 Oct;68(4):1347-1360. doi: 10.1002/hep.29914. Epub 2018 Jul 16.
Nonalcoholic steatohepatitis (NASH) is a progressive, inflammatory form of fatty liver disease. It is the most rapidly rising risk factor for the development of hepatocellular carcinoma (HCC), which can arise in NASH with or without cirrhosis. The inflammatory signals promoting the progression of NASH to HCC remain largely unknown. The propensity of neutrophils to expel decondensed chromatin embedded with inflammatory proteins, known as neutrophil extracellular traps (NETs), has been shown to be important in chronic inflammatory conditions and in cancer progression. In this study, we asked whether NET formation occurs in NASH and contributes to the progression of HCC. We found elevated levels of a NET marker in serum of patients with NASH. In livers from STAM mice (NASH induced by neonatal streptozotocin and high-fat diet), early neutrophil infiltration and NET formation were seen, followed by an influx of monocyte-derived macrophages, production of inflammatory cytokines, and progression of HCC. Inhibiting NET formation, through treatment with deoxyribonuclease (DNase) or using mice knocked out for peptidyl arginine deaminase type IV (PAD4 ), did not affect the development of a fatty liver but altered the consequent pattern of liver inflammation, which ultimately resulted in decreased tumor growth. Mechanistically, we found that commonly elevated free fatty acids stimulate NET formation in vitro.
Our findings implicate NETs in the protumorigenic inflammatory environment in NASH, suggesting that their elimination may reduce the progression of liver cancer in NASH. (Hepatology 2018).
非酒精性脂肪性肝炎(NASH)是一种进行性炎症性脂肪肝疾病。它是肝细胞癌(HCC)发展的风险因素中增长最快的一个,无论是否存在肝硬化,NASH 都可能发展为 HCC。促进 NASH 向 HCC 进展的炎症信号仍知之甚少。中性粒细胞驱逐含有炎症蛋白的不凝结染色质的能力(称为中性粒细胞胞外陷阱(NETs))已被证明在慢性炎症条件和癌症进展中很重要。在这项研究中,我们询问了 NET 的形成是否发生在 NASH 中,并有助于 HCC 的进展。我们发现 NASH 患者血清中 NET 标志物水平升高。在 STAM 小鼠(由新生链脲佐菌素和高脂肪饮食诱导的 NASH)的肝脏中,早期观察到中性粒细胞浸润和 NET 形成,随后是单核细胞衍生的巨噬细胞涌入,炎症细胞因子的产生以及 HCC 的进展。通过使用脱氧核糖核酸酶(DNase)治疗或使用缺乏肽基精氨酸脱氨酶 IV(PAD4)的小鼠来抑制 NET 的形成,虽然不会影响脂肪肝的发展,但改变了随后的肝脏炎症模式,最终导致肿瘤生长减少。从机制上讲,我们发现通常升高的游离脂肪酸会刺激体外 NET 的形成。
我们的发现表明 NET 参与了 NASH 的促肿瘤炎症环境,提示消除 NET 可能会减少 NASH 中肝癌的进展。(《肝脏病学》2018 年)。